As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
© gorodenkoff / Getty Images / iStock
Featured article: Concurrent high-intensity aerobic and resistance exercise modulates systemic release of alarmins (HMGB1, S100A8/A9, HSP70) and inflammatory biomarkers in healthy young men
Intense exercise is a systemic stressor associated with the release of “danger” molecules – alarmins, by damaged or dying cells into systemic circulation to evoke a sterile inflammatory response. Applying concepts from the “danger” model, researchers speculate that the physiological and mechanical stress imposed by unaccustomed, strenuous exercise across repeated, multiple sessions, can activate danger signaling and result in increased alarmins in blood circulation.
In this pilot study, Goh and colleagues investigate the cumulative effects of multiple days of intense exercise training on different alarmins that are normally sequestered in various cellular compartments (nucleus and cytosol) during homeostasis.
Articles
-
-
Biochemical response to cryothermal and radiofrequency exposure of the human myocardium at surgical ablation of atrial fibrillation: a randomized controlled trial
-
Individualized body bioelectrical impedance parameters in newly diagnosed cancer children
-
Rationale and design of the HIT-CF organoid study: stratifying cystic fibrosis patients based on intestinal organoid response to different CFTR-modulators
-
Transcriptional and free radical responses to LVAD therapy
-
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles
-
Total lymphocyte count in cancer patients with lymphopenia treated with intravenous vitamin C: Results of an observational study
-
Comparative in vitro cytotoxic, anti-inflammatory and anti-microbiological activities of two indigenous Venda medicinal plants
-
Membrane cholesterol depletion reduces breast tumor cell migration by a mechanism that involves non-canonical Wnt signaling and IL-10 secretion
-
CD8+ tumor infiltrating lymphocytes strongly correlate with molecular subtype and clinico-pathological characteristics in breast cancer patients from Sudan
© enotmaks / Fotolia
Why publish with us
- Home for all valid research within pre-clinical and translational medicine
- Gold open access and compatible with growing funder mandates
- Specialised sections with expert Section Editors and Editorial Board
- Free access to all content, ensuring a wide dissemination of articles
- High website accesses with more than 18,900 page visits in the last 12 months
- Companion journal to Journal of Translational Medicine
Aims and scope
Translational Medicine Communications is an interdisciplinary forum for all scientifically valid research from across translational medicine. We publish research that focuses on the biology of disease, as well as preclinical and basic research that is closely associated with medicine. Translational Medicine Communications will also consider reviews, methodology articles, protocols and commentaries.
Our aim is to improve transparency and reproducibility within translational medicine, which is why we consider research papers regardless of outcome or significance of findings, as well as protocols for future research. We aim to serve the translational science community by publishing all scientifically valid and technically sound articles and we are dedicated to facilitating the communication between basic and clinical science.
Translational Medicine Communications is the companion journal to Journal of Translational Medicine.
Journal of Translational Medicine considers articles focusing on information derived from human experimentation to optimise the communication between basic and clinical science.
Editor-in-Chief
Francesco Marincola, Refuge Biotechnologies, USA
Annual Journal Metrics
-
Speed
54 days to first decision for reviewed manuscripts only
52 days to first decision for all manuscripts
89 days from submission to acceptance
20 days from acceptance to publication
Usage
27,765 Downloads
8 mentions
